Inflammatory bowel disease (IBD), a relatively common chronic debilitating intestinal illness, is composed of two broadly defined groups, Crohn's disease (CD) and ulcerative colitis (UC). Although several susceptibility genes for CD have been recently described, susceptibility genes exclusive for UC have not been forthcoming. Here, we show that receptor protein-tyrosine phosphatase sigma (PTPRS-encoding PTPs) knockout mice spontaneously develop mild colitis that becomes severe when challenged with two known inducers of colitis. We also demonstrate that E-cadherin and b-catenin, two important adherens junction proteins involved in maintenance of barrier defense in the colon, act as colonic substrates for PTPs. Furthermore, we show that three SNPs (rs886936, rs17130, and rs8100586) that flank exon 8 in the human PTPRS gene are associated with UC. The presence of these SNPs is associated with novel splicing that removes the third immunoglobulin-like domain (exon 9) from the extracellular portion of PTPs, possibly altering dimerization or ligand recognition. We propose that polymorphisms in the human PTPRS gene lead to ulcerative colitis.
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Results and Discussion
The PTPRS-knockout (KO) mice we previously generated display features consistent with human IBD. Mice that survive the high neonatal mortality suffer severe cachexia [1, 2] . Surviving mice appear phenotypically normal except for mild colitis and significant growth failure compared to their wild-type (WT) littermates [1, 3] . In this mouse model, we used the LacZ insert knocked in to show that PTPRS was expressed in the colon (Figures S1A-S1C in the Supplemental Data available online).
We confirmed that the PTPRS-KO mice spontaneously develop colitis (histological score [4] Figure S1F ) and further described crypt branching and architectural distortion that was evident on transmission electron micrographs ( Figure S1H ).
To determine whether the PTPRS-KO mice were further susceptible to experimental colitis, we treated PTPRS-KO mice and wild-type littermates with dextran sodium sulfate (DSS), an established colitis model [5] . As shown in Figure 1D , the PTPRS-KO mice exhibited rectal bleeding within 3 days of DSS treatment, and 100% of the KO mice were bleeding by day 6 compared with 18% of the wild-type group (p < 0.001, log rank test). In addition, the PTPRS-KO mice lost significantly more weight (Figure 1B a ) than their littermates (p = 0.01, Wilcoxon rank sum test). These results, summarized in a disease activity index (DAI) score [4] , show that the PTPRS-KO mice developed severe colitis in this experimental model (Figure 1C a ) . This effect was most dramatically seen in the distal colon as severe ulcers and necrosis ( Figure 1A a ) that were significantly worse in the PTPRS-KO colon, compared with the wild-type controls (histological score; p = 0.001, Wilcoxon rank sum test; Figure 1A b ). The PTPRS-KO mice also had significantly more bacteria translocated to mesenteric lymph nodes compared to the wild-type (p = 0.009, Fisher's exact test; Figure 1E ), again emphasizing the worsening of the existing colitis in these mice.
To further demonstrate that PTPRS-KO mice have an increased susceptibility to colitis, we used the Citrobacter rodentium experimental model of colitis [6] . As shown in Figure 1B b , the PTPRS-KO mice showed significant weight loss, whereas the wild-type mice (and untreated PTPRS-KO mice, not shown) continued to gain weight during the entire experimental period (p < 0.001, Wilcoxon rank sum test). The PTPRS mice had significantly worse median DAI (p < 0.001, Wilcoxon rank sum test; Figure 1C b ) and histological scores (p < 0.001, Wilcoxon rank sum test; Figure 1A b ) compared to wildtype littermates.
Transmission electron micrographs showed that the PTPRS-KO mice challenged with C. rodentium had increased luminal bacterial colonization (Figure 2A) , especially within the colonic crypts; such an increased colonization is rarely observed in healthy colons [7] . This finding was supported by the decrease in bacterial clearance found in the PTPRS-KO mice compared to the wild-type (p < 0.04, Fisher's exact test; data not shown). Furthermore, the presence of luminal bacteria was associated with damage to the epithelial surface, resulting in increased shedding (anoikis) of epithelial cells into the gut lumen ( Figure 2B ). Anoikis is known to be increased in IBD and is associated with early loss of E-cadherin in enterocytes [8, 9] .
We recently identified N-cadherin and b-catenin as in vivo substrates for PTPs in the nervous system [10] . To further understand the pathophysiology by which PTPs caused colitis in these KO mice, we performed substrate-trapping experiments [11] to test whether E-cadherin and b-catenin were in vivo substrates for PTPs in the colon. Figure 2C shows that these proteins might be colonic substrates for PTPs. In support, we found that E-cadherin is hypertyrosine phosphorylated in the colons of the PTPRS-KO mice relative to sibling controls ( Figure 2D ). Both E-cadherin [12, 13] and bcatenin [13] are involved in colonic physiology, with a cadherin-dominant-negative-mouse model expressed in the gut causing intestinal inflammation [14] . Phosphorylation of E-cadherin [15, 16] and b-catenin [17] [18] [19] results in cellular redistribution of E-cadherin and cell disassociation leading to disassembly of the adherens junction [20] . Taken together, these findings point to a potential role for PTPs in maintaining the adherens-junction proteins E-cadherin/b-catenin in a dephosphorylated state and, thereby, enhancing barrier-defense integrity in the colon. Alternatively, loss of PTPs may lead to the disruption of migration along the crypt-villus axis and increased apoptosis, similar to loss E-cadherin in the cadherin-KO-mouse model [21, 22] . Because PTPRS is significantly expressed in the muscularis of the large bowel, it is possible that PTPs may also be involved in dysmotility seen in IBD patients [23] .
Because the PTPRS gene is located on chromosome 17 in the mouse genome and in a region known to be associated with colitis in mice [24] , we investigated, by using a candidate-gene approach, whether PTPRS also played a role in human IBD. Interestingly, PTPRS is located in a syntenic block that is on human chromosome 19p13.3 [25] and that is also associated with human colitis (IBD6 locus). IBD6 was identified in a genome-wide scan of Canadian families and demonstrated linkage to IBD, UC, and CD [26] . The importance of IBD6 as a susceptibility locus has been subsequently confirmed by genome scan meta-analysis [27] . To date, no susceptibility genes for IBD in this locus have been defined [28, 29] . Although MYO9B (located on chromosome 19) showed association with CD and UC, it does not contribute to the original IBD6 observation of linkage because of the low contribution of sibling risk [30] . PTPRS is located in the region of maximum linkage in IBD6 (D19S591/D5S247-GATA21G05) [26] . To determine whether PTPRS is a susceptibility gene for IBD, we first identified 42 SNPs (34 SNPs identified from the HapMap accounting for all Tag SNPs and non-Tag SNPs, and eight additional nonsynonomous SNPs) covering the entire PTPRS gene and flanking regions (chromosome 19, 5140-5259 kb). IBD trios (patients and parents; 409 nuclear families containing 1276 persons; summarized in Table S1 ) from the Hospital for Sick Children and Mount Sinai Hospital in Toronto, Canada, were the genotyped for 33 of these SNPs (nine SNPs, including all eight additional nonsynonymous SNPs and one SNP flanking PTPRS, had minor allele frequency of <1%).
Initial studies of the 33 SNPs with transmission disequilibrium testing (FBAT-e) showed an association with IBD and UC (Tables S5 and S6) , with no association with CD (Table S7 ). Figure 3 shows the linkage-disequilibrium pattern for all 33 SNPs for UC. We then genotyped three SNPs (rs886936, rs17130, and rs8100586) in an additional 37 UC trios from Pittsburgh and performed a joint analysis by using 164 nuclear families containing 175 UC-affected offspring (Toronto and Pittsburgh Trios). Three SNPs, rs886936, rs17130, and rs8100586, showed significant association with UC (additive modeling FBAT-e: p = 0.0039, 0.030, and 0.0071, respectively; recessive modeling FBAT-e: p = 0.0062, 0.050, and 0.00051 respectively). The threemarker haplotype (rs886936, rs17130, and rs8100586) for the combined trios was also significant for association with UC (HBAT-e; p = 0.009). Although the three SNPs are in strong linkage disequilibrium with one another, only rs17130 and rs8100586 form a block (block 5; Figure 3 ). To determine whether either of these two SNPs can explain the association observed in block 5, we applied conditional haplotype-based likelihood testing [31] . This conditional analysis showed that rs8100586 can explain the total association of these two SNPs, whereas rs17130 cannot. In addition, we added rs886936 as an explanatory variable to the single SNP regression model of rs8100586 to determine whether these two SNP have an independent effect. Both rs886936 and rs8100586 showed significant associations in the analysis. The additional analyses suggested that rs886936 and rs8100586 affect disease risk independently, whereas rs17130 has no effect. Permutation testing to account for multiple testing yielded significant values for the two-independent SNP haplotype and rs886936 and rs8100586 singly (p = 0.018, 0.020, and 0.038, respectively; 100,000 permutations with Haploview). There was no further association with the risk genotypes and a number of covariants (family history, Judaism, gender, or disease location; all p > 0.05, Table S2 ). Similarly, no association was seen within the subgroup of Crohn's colitis patients. Further larger replication studies may provide a specific UC phenotype not described here and determine whether PTPRS is associated with Crohn's colitis. Taken together, the animal model and genetic studies indicate that PTPRS may be a susceptibility gene for UC in the IBD6 locus.
These SNPs are located in a physiologically important region of PTPRS, a region that is highly regulated by alternate splicing of exon 8 (termed a microexonB [meB])-a spacer sequence encoding the sequence ELRE ( Figure 4B and Figure S2 ). To determine whether , implying that overall, the the region containing the SNPs found here to be associated with UC leads to alternative splicing, we compared genotyped immortalized lymphoblast-cell lines derived from individuals from the Centre d'Etude du Polymorphisme Humain. Thus, we compared three individuals with the three-marker haplotype associated with UC with three individuals homozygous for the nucleotide not associated with UC. mRNA was isolated from the lymphoblast-cell lines, and a DNA fragment corresponding to amino acids 191-371 of PTPs was amplified with PCR. All three control individuals had the expected 168 amino acid sequence that was a 100% match with either isoform-2 or -3 ( Figure 4A and Figure S2C ). In contrast, the individuals with the three-marker haplotype associated with UC had a novel splice variant of isoform-1 that removed meB and exon 9, along with the normal isoforms-2 and -3 ( Figure 4A and Figure S2C ). This novel splicing resulted in the deletion of the entire third immunoglobulin domain in the ectodomain of the PTPs protein ( Figure 4B ). This splice variant of exon 9 is only inframe in isoform-1, which is the predominant form of PTPRS in the colon [32] . Because this splicing does not occur in the shorter forms of PTPRS (isoform-3 and -4) found in the brain [32] , the neurological abnormalities associated with PTPRS-KO mice [1, 2] are not expected or seen in patients with UC. Although the PTPRS-KO mice lost significantly more weight than the KO mice (Wilcoxon rank sum test; p = 0.013). (C b ) shows that PTPRS-KO mice inoculated with C. rodentium had significant weight loss, whereas the wild-type mice continued to gain weight during the experiment period (p < 0.001 at day 7 and 10, Wilcoxon rank sum test; error bars represent SEM). (C) Disease activity index (DAI) of DSS-treated mice and C. rodentium inoculated mice. (B a ) shows that the DAI score was significantly higher in the PTPRS-KO mice compared with the wild-type mice from the second day to the end of DSS treatment (all p < 0.001, Wilcoxon rank sum test). Control untreated PTPRS-KO and wild-type mice had a DAI score of 0. (B b ) shows that the PTPRS-KO mice had a significantly worse median DAI score on days 7 and 10 after C. rodentium inoculation (both p < 0.001, Wilcoxon rank sum test; error bars represent SEM). (D) Bleeding in DSS-treated mice. Four of 11 PTPRS-KO mice (36%) began to bleed within 3 days of DSS treatment compared to none of the wildtype mice (0/11). After 6 days, all (100%) PTPRS-KO mice compared to only two of the wild-type mice (18%) were bleeding (p < 0.001, log rank test = 16.9, hazard ratio = 0. function of the Ig-like domain of PTPs is unknown, we speculate that it plays a role in either dimerization or ligand binding of PTPs [33] , similar to the alternate splicing in PTPRC (CD45) that is associated with multiple sclerosis [34, 35] . These results indicate that these polymorphisms may disrupt the balance of splice variants in the colon and that alternate splicing of exon 9 may help explain the association with colitis described here. In summary, we show here that SNPs flanking exon 8 within the PTPRS gene have significant association with UC. The three-marker haplotype associated with UC results in novel alternate splicing of meB and exon 9. This novel splicing completely removes the third immunoglobulin like (Ig-like) domain of PTPs, possibly altering ligand recognition or dimerization that may be important for ligand binding. PTPRS is known to be expressed in the human colon [32] , and we demonstrate that PTPRS-KO mice develop spontaneous mild colitis and are susceptible to induced colitis. Taken together, our work identifies PTPRS as a novel gene associated with ulcerative colitis and provides important insight into the pathogenesis of this disease. , and 1340.12) with homozygote C nucleotide at rs8100856 and either GG or AG at rs17130 and rs886936 were compared with three individuals (CEPH 1340.01, 1344.13, and 1362.02) with homozygote nucleotide A for all SNPs resulting in the three-marker haplotype found to be associated with UC. PCR product isolated from the control individuals (left) and the three-marker haplotype associated with UC (right) are shown. The large fragment corresponds to isoform 2 and 3, and the smaller fragment corresponds to the alternate splicing of exon 8 and 9 in isoform 1. (B) Novel alternate splicing of meB and exon 9. Alternate splicing in rs17130, rs886939, and rs8100586 three-marker haplotype is shown. Exon 9, Ig-like domain 3 (Ig3, shown in orange), is spliced out along with meB (yellow, usually found in this isoform-1). This splicing variant is only inframe in isoform-1.
